As the prevalence of obesity rises, so do related chronic conditions such as diabetes, heart disease and hypertension, creating a massive market for treatments like GLP-1 drugs
In trials, people taking retatrutide lost an average of 24% of their body weight over 48 weeks, compared to around 15-17% with Wegovy (semaglutide) and 15-22% with Mounjaro (tirzepatide)
Plus, with our unlimited referral program , both you and anyone you refer will receive a discount, so you can save money while helping others take charge of their health, too
1 Reconstitute with sterile bacteriostatic water
Talk with your doctor about the proper way to self-administer the drug
If earlier increases felt manageable, your provider may feel more comfortable adjusting again